Evidence map›Paper›PMID 33269544›Full record

ArticleTransfusion medicine (Oxford, England)2021

Impact of Covid-19 epidemic on the activities of a blood centre, transfusion support for infected patients and clinical outcomes.

Anna Quaglietta, Antonio Nicolucci, Raffaella Posata, Antonella Frattari, Giustino Parruti, Patrizia Accorsi

Abstract read
In one paragraph

Article in Transfusion medicine (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Impact of Shelf-Life Extension on Platelet Availability: Results from an Inventory Management Modeling Study.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2024
    Article
  2. Observational
  3. Review
  4. Review
  5. Observational
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anna QuagliettaDepartment of Haematolgy and Oncology, Center of Transfusion Medicine, Pescara General Hospital, Pescara, Italy.ORCID https://orcid.org/0000-0002-3157-0132
Antonio NicolucciDepartment of Clinical Epidemiology, Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy.
Raffaella PosataDepartment of Medical, Oral and Biotechnological Sciences, Unit of Clinical Molecular Biology and Predictive Medicine, University G. d'Annunzio of Chieti-Pescara, Chieti-Pescara, Italy.
Antonella FrattariDepartment of Emergency, Unit of Anesthesia and Intensive Care, Pescara General Hospital, Pescara, Italy.
Giustino ParrutiDepartment of Medicine, Infectious Diseases Unit, Pescara General Hospital, Pescara, Italy.
Patrizia AccorsiDepartment of Haematolgy and Oncology, Center of Transfusion Medicine, Pescara General Hospital, Pescara, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe evaluated how the Severe Acute Respiratory disease from Coronavirus 2 (SARS-CoV-2) epidemic impacted transfusion services, transfusion support required by Covid-19 patients and their clinical outcome.

backgroundIn Italy, the first confirmed case of SARS-CoV-2 infection was registered on 21 February 2020. As of 20 April, about 250 000 cases were registered, 1143 of which were in the province of Pescara.

methodsWe compared transfusion services provided by the blood centre of Pescara between 1 March and 20 April 2019 and between 1 March and 20 April 2020. We assessed the number and type of blood components donated, those transfused in the various hospital departments and those transfused to Covid-19 patients.

resultsCompared to 2019, we documented a decrease of 32% in the number of donations. The number of transfusions increased by 139% in the infectious diseases department (IDD), dedicated to Covid-19 patients, and by 76% in the intensive care unit (ICU), whereas it markedly decreased in the other departments. Of 299 patients with Covid-19, 60 were transfused (20.1%). Transfused patients in the ICU were significantly younger than those in IDD and had a lower number of lymphocytes, lower post-transfusion increment of haemoglobin levels and higher D-dimer and C reactive protein values. Mortality rate was 60.7% among transfused patients in the ICU and 39.0% among those in the IDD (p = 0.02).

conclusionThe Covid-19 epidemic had a profound impact on transfusion activities. The important blood demand for Covid-19 patients was satisfied because of the reduction in activities in other hospital wards. Covid-19-positive transfused patients showed a very poor prognosis.

Indexed as

SARS-CoV-2AgedAged, 80 and overBlood BanksBlood Component TransfusionBlood DonorsBlood TransfusionCOVID-19FemaleHemoglobinsHumansIntensive Care UnitsItalyMaleMiddle AgedPandemicsHemoglobinsCovid-19mortalitytransfusion efficacytransfusion support

Identifiers

PMID33269544
PMCPMC7753726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.